π΅οΈ Vertex Pharmaceuticals Inc / MA ($VRTX)
SEC insider & ownership activity, last 12 months Β· CIK 875320 Β· every row links its SEC filing
Over the last 12 months insiders sold $158.5M against $5.8M of open-market buying. Jeffrey M. Leiden sold $60.9M through a 10b5-1 trading plan in 17 lots (NovβDec). 3 planned sales are pending, the largest $3.1M (Bozic Carmen). No red-flag 8-Ks in the window.
π¨ 4 signals active β
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $5.8M (4 lots) Β· 13 sellers, $158.5M (95 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jeffrey M. Leiden | 0 | β | 17 | $60.9M | Dec 3, 2025 |
| Sachdev Amit | 0 | β | 9 | $28.4M | Feb 25, 2026 |
| Kewalramani Reshma | 2 | $3.9M | 13 | $19.7M | Feb 27, 2026 |
| Bozic Carmen | 0 | β | 10 | $11.3M | Jun 26, 2026 |
| Charles F. Wagner Jr. | 0 | β | 3 | $10.8M | Jan 6, 2026 |
| Tatsis Ourania | 0 | β | 8 | $6.5M | Jul 2, 2026 |
| McKechnie Duncan | 0 | β | 5 | $5.7M | Jul 2, 2026 |
| Biller Jonathan | 0 | β | 7 | $4.1M | Feb 25, 2026 |
| Atkinson Edward Morrow III | 0 | β | 5 | $3.6M | Feb 25, 2026 |
| Mark E. Bunnage | 0 | β | 5 | $3.0M | May 15, 2026 |
| Liu Joy | 0 | β | 5 | $2.1M | Jul 1, 2026 |
| Ambrose Kristen | 0 | β | 5 | $2.0M | Feb 26, 2026 |
| Bruce I. Sachs | 2 | $1.9M | 0 | β | Aug 6, 2025 |
| Sangeeta N. Bhatia | 0 | β | 3 | $371K | May 4, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Capital World Investors | 10.1% | 13G | May 14, 2026 | filing β | |
| Capital Research Global Investors | 8.3% | 13G | May 14, 2026 | filing β | |
| Vanguard Capital Management | 7.5% | 13G | Apr 30, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Tatsis Ourania | $787K | Jul 2, 2026 | filing β |
| McKechnie Duncan | $800K | Jul 2, 2026 | filing β |
| Liu Joy | $416K | Jul 1, 2026 | filing β |
| Bozic Carmen | $288K | Jun 26, 2026 | filing β |
| Bozic Carmen | $471K | Jun 18, 2026 | filing β |
| Bozic Carmen | $1.8M | Jun 15, 2026 | filing β |
| Bozic Carmen | $785K | Jun 5, 2026 | filing β |
| Liu Joy | $364K | Jun 1, 2026 | filing β |
| Bozic Carmen | $888K | May 29, 2026 | filing β |
| Bozic Carmen | $614K | May 15, 2026 | filing β |
| Mark E. Bunnage | $15K | May 15, 2026 | filing β |
| Bozic Carmen | $3.1M | May 12, 2026 | filing β |
| Biller Jonathan | $2.2M | May 6, 2026 | filing β |
| Sangeeta N. Bhatia | $135K | May 4, 2026 | filing β |
| Liu Joy | $469K | May 1, 2026 | filing β |
| Liu Joy | $439K | Apr 1, 2026 | filing β |
| Bozic Carmen | $1.1M | Mar 27, 2026 | filing β |
| Bozic Carmen | $1.1M | Mar 13, 2026 | filing β |
| McKechnie Duncan | $1.3M | Mar 11, 2026 | filing β |
| McKechnie Duncan | $1.2M | Mar 4, 2026 | filing β |
| Liu Joy | $442K | Mar 2, 2026 | filing β |
| Kewalramani Reshma | $19.7M | Feb 27, 2026 | filing β |
| Bozic Carmen | $1.1M | Feb 27, 2026 | filing β |
| McKechnie Duncan | $2.4M | Feb 25, 2026 | filing β |
| Tatsis Ourania | $126K | Feb 25, 2026 | filing β |
| Mark E. Bunnage | $302K | Feb 25, 2026 | filing β |
| Atkinson Edward Morrow III | $325K | Feb 25, 2026 | filing β |
| Sachdev Amit | $898K | Feb 25, 2026 | filing β |
| Biller Jonathan | $460K | Feb 25, 2026 | filing β |
| Sachdev Amit | $27.5M | Feb 19, 2026 | filing β |
| Tatsis Ourania | $174K | Feb 18, 2026 | filing β |
| Biller Jonathan | $589K | Feb 18, 2026 | filing β |
| Mark E. Bunnage | $560K | Feb 18, 2026 | filing β |
| Atkinson Edward Morrow III | $387K | Feb 18, 2026 | filing β |
| Mark E. Bunnage | $1.2M | Feb 17, 2026 | filing β |
| Tatsis Ourania | $298K | Feb 17, 2026 | filing β |
| Biller Jonathan | $1.2M | Feb 17, 2026 | filing β |
| Atkinson Edward Morrow III | $994K | Feb 17, 2026 | filing β |
| Biller Jonathan | $493K | Feb 13, 2026 | filing β |
| Sangeeta N. Bhatia | $133K | Feb 13, 2026 | filing β |
| Tatsis Ourania | $750K | Feb 13, 2026 | filing β |
| Biller Jonathan | $886K | Feb 11, 2026 | filing β |
| Atkinson Edward Morrow III | $806K | Feb 11, 2026 | filing β |
| Mark E. Bunnage | $931K | Feb 11, 2026 | filing β |
| Tatsis Ourania | $215K | Feb 11, 2026 | filing β |
| Tatsis Ourania | $2.1M | Jan 7, 2026 | filing β |
| Charles F. Wagner Jr. | $4.4M | Jan 6, 2026 | filing β |
| Charles F. Wagner Jr. | $3.2M | Dec 3, 2025 | filing β |
| Charles F. Wagner Jr. | $3.2M | Dec 3, 2025 | filing β |
| Tatsis Ourania | $2.0M | Dec 3, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 6, 2026 | filing β |
| Reg FD disclosure (7.01) | Jul 6, 2026 | filing β |
| Other events (8.01) | Jul 6, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing β |
| Officer/director changes (5.02) | May 13, 2026 | filing β |
| Shareholder vote (5.07) | May 13, 2026 | filing β |
| Earnings (2.02) | May 4, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing β |
| Officer/director changes (5.02) | Apr 28, 2026 | filing β |
| Other events (8.01) | Mar 31, 2026 | filing β |
| Earnings (2.02) | Feb 12, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing β |
| Earnings (2.02) | Nov 3, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing β |
| Earnings (2.02) | Aug 4, 2025 | filing β |
| Officer/director changes (5.02) | Aug 4, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 4, 2025 | filing β |